DV
Dividend Vision

NUVB — Nuvation Bio Inc.

Nuvation Bio Inc. (NUVB)

Total return is -37.8% over the past 6 years, 183.6 points behind SPY at 145.8%. Its deepest 1-year drawdown was 57.5%.

Nuvation Bio Inc. is an equity stock trading on public markets, operating as a single-stock holding rather than a diversified fund. The company does not currently pay dividends, as indicated by its N/A distribution rate and lack of specified distribution frequency. This security may appeal primarily to growth-oriented investors seeking exposure to the biotech sector rather than those focused on income generation.

NUVB key facts

Asset type
Stock
Asset class
Equity
Inception date
08/24/2020
Distribution frequency
None
Last close
$6.22
Market cap
$2,141,851,648
Average volume
13326900.0
Beta
1.525
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.42